SCHEMBL3555977

SCHEMBL3555977

N#CC(=Cc1ccc(-n2cccn2)cc1)C(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
KMT2A Q03164 7/20 0.59
KDM4E B2RXH2 4/20 0.59
PKM P14618 2/20 0.59
ATM Q13315 1/20 0.59
MAPT P10636 3/20 0.55
MEN1 O00255 3/20 0.55
EGFR P00533 4/20 0.53
ERBB2 P04626 4/20 0.53
POLB P06746 2/20 0.49
MAPK1 P28482 2/20 0.49
HPGD P15428 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MCL1 Q07820 1/20 0.43
HDAC4 P56524 1/20 0.41
RGS12 O14924 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555974 1.00 ALDH1A1 (0.59) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL3563600 0.82 MAPT (0.55) ALDH1A1KMT2AKDM4EPKMMAPT
SCHEMBL3563599 0.82 MAPT (0.55) ALDH1A1KMT2AKDM4EPKMMAPT
SCHEMBL32688419 0.79 MAPT (0.57) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL2957854 0.78 ALDH1A1 (0.79) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL19888568 0.78 ALDH1A1 (0.79) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL20959563 0.78 ALDH1A1 (0.79) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL3564703 0.76 KMT2A (0.53) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL3564700 0.76 KMT2A (0.53) ALDH1A1KMT2AKDM4EPKMATM
SCHEMBL3557982 0.75 KMT2A (0.54) ALDH1A1KMT2AKDM4EPKMATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705029-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2010-04-27 US disclosed
EP-1732900-A4 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP (US) 2007-12-12 EP disclosed
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-11-22 US disclosed
US-7202232-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-04-10 US disclosed
EP-1732900-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. 2005-12-08 US disclosed
WO-2005091752-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses IL1B, IL6, TLR4 ALDH1A1 472/4885KMT2A 4809/4885KDM4E 4711/4885
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES IL1B, IL6, TLR4 ALDH1A1 472/4885KMT2A 4809/4885KDM4E 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.